T. Everett Jones, MD - Research

Research at a glance

Top areas of exploration

Heart Transplantation , 1 publications
Anesthesia , 1 publications
COVID-19 , 1 publications
Anesthesia, Cardiac Procedures , 1 publications

Research activity

11 publications

13 citations

Why is this important?

Active clinical trials

Octapharma LEX-210

This is a multicentre, prospective, randomised, double-blinded, group-sequential, parallel-group, adaptive design, phase 3 study to demonstrate the haemostatic efficacy and safety of four-factor prothrombin complex concentrate, OCTAPLEX, in patients鈥�

Investigator: T. Everett Jones
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

Phase 3 Trial of PROTHROMPLEX TOTAL for Reversal of Direct Oral Factor Xa Inhibitor-induced Anticoag

The aim of this study is to find out the effects of TAK-330 compared with four-factor prothrombin complex concentrate (4F-PCC) as part of standard treatment other than Prothromplex Total for anticoagulation reversal in participants treated with鈥�

Investigators: T. Everett Jones, Yong G Peng
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

My publications

11 publications

2025

Survey of Extracorporeal Life Support Application in Lung Transplantation

Clinical Transplantation

2025

The Year in Cardiothoracic Transplant Anesthesia: Selected Highlights From 2022 Part II: Cardiac Transplantation.

Journal of cardiothoracic and vascular anesthesia

鈥�

2024

Aortic Valve Injury During Thoracic Endovascular Aortic Repair Requiring Emergent Surgical Aortic Valve Replacement.

Journal of cardiothoracic and vascular anesthesia

鈥�

2024

Impella 5.5 Use in the Setting of Severe Aortic Insufficiency: A Relative Contraindication.

Annals of thoracic surgery short reports

鈥�

2023

Thoracoscopic Left Atrial Appendage Exclusion for Atrial Fibrillation Patients Intolerant to Anticoagulation.

Innovations (Philadelphia, Pa.)

鈥�

BOB体育